Aitia
PrivateLast Round
Series D
Jul 9, 2019
Total Funding Raised
$59M
Company Overview
Aitia is an AI-enabled biotechnology company that focuses on drug discovery and development by applying Causal AI and creating 'Gemini Digital Twins'. These digital twins are mechanistic, in-silico models of human disease biology that simulate disease progression and drug responses at an individual patient level. The company collaborates with biopharmaceutical partners to uncover novel drug targets, predict patient responses, and optimize clinical trials, with a primary focus on oncology, immunology, and neurodegenerative diseases. Aitia was formerly known as GNS Healthcare and rebranded in January 2023 to reflect its focus on causality in discovering new drugs.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aitia Comps
Public and private peers based on sector, stage, and business model.
Aitia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jul 9, 2019 | ||||
| Series D | Aug 23, 2017 | ||||
| Strategic | May 23, 2016 | ||||
| Series C | Dec 8, 2015 | ||||
| Series B | Jan 29, 2014 | ||||
Seed | Apr 6, 2012 |
Aitia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cigna Ventures | Series D |
| Merck Global Health Innovation Fund | Series D |
| GHO Capital | Series D |
| Amgen Ventures | Series D |
| Alexandria Venture Investments | Series D |
| Cigna Investments | Series D |
| Zambon Pharmaceuticals | Series D |
Aitia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aitia's valuation, stock price, and market status.
